Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIFA
3326
All In FutureTech Alliance Inc
AIFA
$10.3M
| $34.3K | ﹤0.01% |
4,500
-317
| -7% | -$1.6K |
|
3327
Bullfrog AI
BFRG
$10.3M
| $34.3K | ﹤0.01% |
+19,800
| New | +$55.3K |
|
3328
8x8 Inc
EGHT
$269M
| $34K | ﹤0.01% |
15,300
-208,895
| -93% | -$508K |
|
|
NUTX
3329
Nutex Health
NUTX
$1.01B
| $33.9K | ﹤0.01% |
5,690
+4,641
| +442% | +$33.5K |
|
|
QTEX
3330
QTREX Quantum
QTEX
$50.1M
| $33.8K | ﹤0.01% |
+24,497
| New | +$47.8K |
|
3331
Smith Micro Software
SMSI
$14.5M
| $33K | ﹤0.01% |
2,988
-1,281
| -30% | -$15.1K |
|
|
LFLY
3332
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
| $32.8K | ﹤0.01% |
+16,301
| New | +$37.9K |
|
|
SVRE
3333
SaverOne 2014 Ltd
SVRE
$6.17M
| $31.9K | ﹤0.01% |
9
-3
| -25% | -$16.7K |
|
3334
SciSparc
SPRC
$4.08M
| $31.8K | ﹤0.01% |
+210
| New | +$48.5K |
|
|
SOGP
3335
Sound Group
SOGP
$50.3M
| $31.4K | ﹤0.01% |
15,158
-800
| -5% | -$2.16K |
|
3336
Dyadic International
DYAI
$38.3M
| $31.4K | ﹤0.01% |
21,200
+4,300
| +25% | +$7.52K |
|
3337
CPI Aerostructures
CVU
$66.2M
| $31.4K | ﹤0.01% |
12,700
-9,000
| -41% | -$22.5K |
|
3338
AN2 Therapeutics
ANTX
$193M
| $30.7K | ﹤0.01% |
+14,300
| New | +$34K |
|
|
IMDX
3339
Insight Molecular Diagnostics
IMDX
$150M
| $30.7K | ﹤0.01% |
10,418
-1,800
| -15% | -$4.95K |
|
|
SACH
3340
Sachem Capital Corp
SACH
$39.1M
| $30K | ﹤0.01% |
+11,600
| New | +$35.9K |
|
3341
BeyondSpring
BYSI
$47.3M
| $30K | ﹤0.01% |
+12,500
| New | +$31K |
|
3342
Milestone Scientific
MLSS
$35.3M
| $30K | ﹤0.01% |
43,897
-46,600
| -51% | -$31K |
|
3343
Microbot Medical
MBOT
$116M
| $29.9K | ﹤0.01% |
29,295
-52,412
| -64% | -$53.9K |
|
3344
PodcastOne
PODC
$102M
| $29.7K | ﹤0.01% |
17,687
-4,961
| -22% | -$9.46K |
|
|
BQ
3345
Boqii Holding Ltd
BQ
$5.87M
| $29.4K | ﹤0.01% |
+5,586
| New | +$20.7K |
|
3346
Evogene
EVGN
$5.7M
| $29.1K | ﹤0.01% |
4,470
-10
| -0.2% | -$70 |
|
|
TRVN
3347
DELISTED
Trevena, Inc.
TRVN
| $28.8K | ﹤0.01% |
5,282
-815
| -13% | -$7.75K |
|
3348
Wheels Up
UP
$208M
| $28.4K | ﹤0.01% |
+750
| New | +$35.9K |
|
3349
Stran & Co
SWAG
$36.7M
| $28K | ﹤0.01% |
25,031
+5,300
| +27% | +$6.34K |
|
3350
Cadrenal Therapeutics
CVKD
$6.23M
| $28K | ﹤0.01% |
3,966
-5,910
| -60% | -$40.9K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.